ATI Medication Decongestant-Rebound congestion PDF

Preview

Summary

ATI medication...

Description

STUDENT NAME MEDICATION CATEGORY CLASS

Pamela Cube DECONGESTANT-Rebound congestion

REVIEW MODULE CHAPTER

PURPOSE OF MEDICATION

Expected Pharmacological Action Sympathomimetic decongestants stimulate alpha1-adrenergic receptor, causing reduction in the inflammation of the nasal membranes

Therapeutic Use -This medication can be used to treat allergic or non allergic rhinitis by relieving nasal stuffiness. -Acts as a decongestant for clients who have sinusitis and the common cold.

Complications REBOUND CONGESTION Secondary to prolonged use of topical agents

Medication Administration -When administering nasal drops, instruct clients to be in the lateral head-low position to increase the desired effect and to prevent swallowing the medication. -Drops are preferred for children because they can be administered precisely and toxicity can be prevented. -When nasal spray preparations are prescribed, reinforce teaching with clients regarding their proper use. -Pseudoephedrine and ephedrine can product effects similar to amphetamine and are easily converted into amphetamine. These medications are available without a prescription. However, they must be purchased with identification.

Contraindications/Precautions WARNINGS: *Pregnancy: Phenylephrine, pseudoephedrine; Safety not established.*Lactation: Phenylephrine, pseudoephedrine: Safety not established. -These medications are contraindicated in clients who have closed-angle glaucoma -Use cautiously in clients who have coronary artery disease, hypertension, cerebrovascular disease, and dysrhythmias.

Nursing Interventions Taper use and discontinue medication using one nostril at a time

Interactions

Client Education Evaluation of Medication Effectiveness Depending on therapeutic intent, effectiveness is evidenced by improvement of manifestation (relie of congestion increased ease of breathing).

ACTIVE LEARNING TEMPLATES

-Use for short-term therapy, no more than 3 to 5 days -Be aware of the differences between topical and oral agents. *topical agents are usually more effective and work faster *topical agents have a shorter duration *Vasoconstriction and CNS stimulation are uncommon with topica agents, but are a concern with oral agents. *Oral agents do not lead to rebound congestion -Use topical decongestants for no longer than 3 to 5 days to avoi rebound congestion -Do not exceed recommended doses

THERAPEUTIC PROCEDURE A7...